Evaluation of immunity in the evolution of the severe or mild form of COVID-19

Not Applicable

Recruiting

• Conditions: coronavirus; B97.2

• Registration Number: RBR-62zdkk
• Lead Sponsor: Hospital Universitário de Brasília

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2020-07-17
• Last Update Posted: 29 May 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: Not specified
• Target Recruitment: Not specified

Inclusion Criteria

patients of both genders; diagnosed with COVID-19; age over 18

Exclusion Criteria

do not fill out the informed consent form; age under 18 years

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Increase greater than 20%; in circulating cytokines and chemokines; measured in peripheral blood collected at D10 from hospitalized patients

Secondary Outcome Measures

Name	Time	Method
Secondary outcomes are not expected